Company Monitoring Page for Cytokinetics

latest headlines for company on cafepharma

FDA Review: Alnylam, Cytokinetics, Eli Lilly and More
BioSpace
Sun, 10/9/22 - 06:06 pm
Tags:
FDA, Alnylam, Cytokinetics, Eli Lilly, Owlet, Boston Cell Standards, Kiromic Biopharma, Entera Bio, Transcenta Holdings, Kira Pharmaceuticals, Kite Pharma, Poxel, Seneca Therapeutics
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Tags:
Cytokinetics, Amgen, heart failure, Omecamtiv Mecarbil, cardiovascular disease
Cytokinetics hopes to resurrect omecamtiv
EP Vantage
Wed, 01/19/22 - 11:08 am
Tags:
Cytokinetics, Omecamtiv Mecarbil, heart failure
Abandoned by Amgen, Cy­to­ki­net­ics lands $50M upfront deal for Chinese rights to heart failure prospect
Fierce Biotech
Tue, 12/21/21 - 10:34 am
Tags:
Cytokinetics, heart failure, Omecamtiv Mecarbil, Amgen, China, Ji Xing Pharmaceuticals
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
Tags:
ALS, Amylx, Biogen, Ionis Pharmaceuticals, AB Science, Cytokinetics
Cytokinetics heart drug succeeds in mid-stage study, boosting shares
BioPharma Dive
Mon, 07/19/21 - 11:05 pm
Tags:
Cytokinetics, clinical trials, CK-274, obstructive hypertrophic cardiomyopathy
ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure
Fierce Biotech
Mon, 05/17/21 - 10:48 am
Tags:
Amgen, Cytokinetics, ACC, Omecamtiv Mecarbil
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
Fierce Biotech
Mon, 05/3/21 - 10:51 am
Tags:
Astellas, Cytokinetics, biobucks
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Endpoints
Mon, 11/23/20 - 10:16 pm
Tags:
Amgen, Cytokinetics, omecamtiv, clinical trials
AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
Mon, 11/16/20 - 10:13 am
Tags:
AHA, Omecamtiv Mecarbil, Amgen, Cytokinetics, heart failure
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Thu, 10/8/20 - 11:19 pm
Tags:
Amgen, Cytokinetics, Servier, clinical trials, Omecamtiv Mecarbil, cardiovascular disease
Amgen heart drug passes interim check, setting up year-end readout
BioPharma Dive
Wed, 02/26/20 - 11:24 pm
Tags:
Amgen, Omecamtiv Mecarbil, Cytokinetics
Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS
Endpoints
Sun, 05/5/19 - 06:59 pm
Tags:
Cytokinetics, clinical trials, reldesemtiv, ALS
Amgen and partners begin second phase 3 trial of omecamtiv mecarbil in patients with heart failure
Pharmaceutical Business Review
Fri, 02/22/19 - 10:04 am
Tags:
Amgen, heart failure with reduced ejection fraction, Omecamtiv Mecarbil, Cytokinetics, Servier
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
Endpoints
Mon, 06/18/18 - 10:00 am
Tags:
Cytokinetics, clinical trials, reldesemtiv, Tirasemtiv, spinal muscular atrophy, Astellas
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
Tags:
biotech, Axovant Sciences, intepirdine, SAGE Therapeutics, brexanolone, AbbVie, risankizumab, Global Blood Therapeutics, GBT-440, DBV Technologies, Viaskin Peanut, Cytokinetics, Amicus Therapeutics, ATB200, Spark Therapeutics, Bluebird Bio, Revance Therapeutics, RT002
Cytokinetics inches forward with heart failure program
BioPharma Dive
Thu, 08/3/17 - 10:57 am
Tags:
Cytokinetics, Omecamtiv Mecarbil, Amgen, heart failure, Japan
Cytokinetics reports 4Q loss
Yahoo/AP
Tue, 02/16/16 - 07:45 pm
Tags:
Cytokinetics, earnings
Cytokinetics, Amgen drug shows promise in heart failure study
Yahoo/Reuters
Mon, 11/9/15 - 10:28 am
Tags:
Amgen, Cytokinetics, omecamtiv, chronic heart failure
Amgen, Cytokinetics heart failure drug succeeds in mid-stage study
Yahoo/Reuters
Tue, 10/27/15 - 09:56 am
Tags:
Amgen, Cytokinetics, Omecamtiv Mecarbil, chronic heart failure

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.